NEW YORK (WBAP/KLIF News) – As pharmaceutical companies race to develop treatments to battle COVID-19 and its mutations, Pfizer confirmed Tuesday its experimental pill is effective against the omicron variant. The company released the results of a 2,246-person study that the oral antiviral reduced hospitalizations and deaths by almost 89% among high-risk adults when taken…… MORE
